...
首页> 外文期刊>PLoS One >Safety of bedside surgical tracheostomy during COVID-19 pandemic: A retrospective observational study
【24h】

Safety of bedside surgical tracheostomy during COVID-19 pandemic: A retrospective observational study

机译:Covid-19大流行期间床边外科气管术的安全性:回顾性观察研究

获取原文
           

摘要

Data regarding safety of bedside surgical tracheostomy in novel coronavirus 2019 (COVID-19) mechanically ventilated patients admitted to the intensive care unit (ICU) are lacking. We performed this study to assess the safety of bedside surgical tracheostomy in COVID-19 patients admitted to ICU. This retrospective, single-center, cohort observational study (conducted between February, 23 and April, 30, 2020) was performed in our 45-bed dedicated COVID-19 ICU. Inclusion criteria were: a) age over 18 years; b) confirmed diagnosis of COVID-19 infection (with nasopharyngeal/oropharyngeal swab); c) invasive mechanical ventilation and d) clinical indication for tracheostomy. The objectives of this study were to describe: 1) perioperative complications, 2) perioperative alterations in respiratory gas exchange and 3) occurrence of COVID-19 infection among health-care providers involved into the procedure. A total of 125 COVID-19 patients were admitted to the ICU during the study period. Of those, 66 (53%) underwent tracheostomy. Tracheostomy was performed after a mean of 6.1 (± 2.1) days since ICU admission. Most of tracheostomies (47/66, 71%) were performed by intensivists and the mean time of the procedure was 22 (± 4.4) minutes. No intraprocedural complications was reported. Stoma infection and bleeding were reported in 2 patients and 7 patients, respectively, in the post-procedure period, without significant clinical consequences. The mean PaO 2 / FiO 2 was significantly lower at the end of tracheostomy (117.6 ± 35.4) then at the beginning (133.4 ± 39.2) or 24 hours before (135.8 ± 51.3) the procedure. However, PaO 2 /FiO 2 progressively increased at 24 hours after tracheostomy (142 ± 50.7). None of the members involved in the tracheotomy procedures developed COVID-19 infection. Bedside surgical tracheostomy appears to be feasible and safe, both for patients and for health care workers, during COVID-19 pandemic in an experienced center.
机译:缺乏关于患有新型冠状病毒(Covid-19)的床边外科气管造口术的数据缺乏缺乏冠状病毒2019(Covid-19)的机械通风患者(ICU)。我们进行了这项研究,以评估床边外科气管造口术的安全性,在Covid-19患者中承认ICU。在我们的45张床上专用Covid-19 ICU中进行了这种回顾性,单中心,队列队列观察研究(2月23日和4月30日,30日)进行。纳入标准是:a)年龄超过18岁; b)确诊对Covid-19感染的诊断(鼻咽/口腔拭子); c)侵袭性机械通气和D)气管造福术的临床指示。本研究的目的是描述:1)围手术期并发症,2)呼吸气体交换的围闭改变,3)疗养医疗服务提供者的Covid-19感染发生。在研究期间,共参加了125名Covid-19患者。其中66(53%)进行了气管造口术。自ICU入院以来的均值为6.1(±2.1)天后进行气管造口术。大部分气管遗传术(47/66,71%)由强烈主义者进行,并且程序的平均时间为22(±4.4)分钟。没有报告颅腺细胞复杂性。在术后2名患者和7名患者中报告了造口感染和出血,没有显着的临床后果。在气管造口术(117.6±35.4)结束时平均pao 2 / fio 2在开始(133.4±39.2)或24小时之前(135.8±51.3)的程序。然而,PAO 2 / FIO 2在气管造口术后24小时逐渐增加(142±50.7)。涉及气管切开程序的成员都没有开发Covid-19感染。床边外科气管造口术似乎是可行和安全的,适用于患者和医疗保健工作者,在经验丰富的中心Covid-19大流行期间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号